Our previous research has identified FCN as an inactivator of NR4A1-mediated responses and showed that treatment of pancreatic cancer cells with FCN was highly effective at inhibiting cell growth and survival [10]. This evidence concerns the gene NR4A1 and familial pancreatic carcinoma.